Camp4 Therapeutics (CAMP) EBITDA Margin (2023 - 2026)
Camp4 Therapeutics (CAMP) reported EBITDA Margin of 1010.12% for Q1 2026, up 51668.0% on a YoY basis from N/an in Q1 2025, and up 72.49% sequentially from 3671.26% in Q4 2025.
Camp4 Therapeutics (CAMP) EBITDA Margin (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of EBITDA Margin data on file, last reported at 1010.12% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 51668.0% year-over-year to 1010.12%; the trailing twelve-month figure through Mar 2026 stood at 1335.18% (up 219542.0% YoY), and the FY2025 full-year result was 1502.43%, up 663990.0% from the prior year.
- EBITDA Margin advanced to 1010.12% in Q1 2026, from 3671.26% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 870.27% in Q2 2025 to a low of 3671.26% in Q4 2025.
- A 4-year average of 2067.6% and a median of 1717.11% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 151881 bps in 2025 and surged 51668 bps in 2026, its largest moves.
- Tracing CAMP's EBITDA Margin over 4 years: stood at 3525.14% in 2023, then soared by 39 bps to 2152.45% in 2024, then plunged by 71 bps to 3671.26% in 2025, then jumped by 72 bps to 1010.12% in 2026.
- Business Quant data shows CAMP's EBITDA Margin at 1010.12% in Q1 2026, 3671.26% in Q4 2025, and 1717.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -1,010.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,010.12% |
| Dec 31, 2025 | -3,671.26% |
| Sep 30, 2025 | -1,717.11% |
| Jun 30, 2025 | -870.27% |
| Mar 31, 2025 | -1,526.81% |
| Dec 31, 2024 | -2,152.45% |
| Sep 30, 2023 | -3,525.14% |